dimyristoylphosphatidylcholine has been researched along with Atherogenesis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdollahi, E; Banach, M; Jaafari, MR; Momtazi-Borojeni, AA; Sahebkar, A; Watts, GF | 1 |
| Cho, BH; Chung, BH; Nakamura, MT; Odintsov, BM; Park, JR; Wallig, MA | 1 |
2 other study(ies) available for dimyristoylphosphatidylcholine and Atherogenesis
| Article | Year |
|---|---|
Negatively-charged Liposome Nanoparticles Can Prevent Dyslipidemia and Atherosclerosis Progression in the Rabbit Model.
Topics: Animals; Atherosclerosis; Cholesterol; Dimyristoylphosphatidylcholine; Dyslipidemias; Liposomes; Nanoparticles; Phosphorylcholine; Rabbits | 2022 |
Synthetic dimyristoylphosphatidylcholine liposomes assimilating into high-density lipoprotein promote regression of atherosclerotic lesions in cholesterol-fed rabbits.
Topics: Animals; Aorta; Atherosclerosis; Cholesterol; Cholesterol, Dietary; Dimyristoylphosphatidylcholine; In Vitro Techniques; Infusions, Intravenous; Lipoproteins, HDL; Liposomes; Male; Rabbits | 2010 |